• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解肺表面活性剂在健康和疾病中的基本生物物理概念。

Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.

机构信息

Department of Biochemistry and Molecular Biology, Faculty of Biology, Complutense University, Madrid, Spain.

Research Institute "Hospital 12 de Octubre", Complutense University, Madrid, Spain.

出版信息

Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F443-F451. doi: 10.1136/archdischild-2018-315413. Epub 2018 Dec 14.

DOI:10.1136/archdischild-2018-315413
PMID:30552091
Abstract

Pulmonary surfactant (PS) is a lipid-protein complex essential to stabilise the delicate structure of mammalian alveoli along with successive compression-expansion respiratory cycles. To do so, surfactant reduces dramatically surface tension at the air-liquid interface, an activity that depends critically on a proper lipid composition and the presence of some specific surfactant proteins. Lack or dysfunction of this system is associated with severe respiratory pathologies, which are in some cases treated by supplementation with exogenous surfactant materials. The biophysical function and performance of PS, in health and disease, are directly influenced by its composition, structure and mechanical properties. This review summarises the main biophysics concepts behind the mechanisms that define surfactant function in a healthy lung and in pathological situations. It also revises some of the most useful biophysical techniques that provide information about surfactant-related processes. Finally, translational biophysics will be invoked to illustrate how biophysical studies may contribute to understand the role of surfactant in health and disease and to design better surfactant-based therapeutic approaches.

摘要

肺表面活性剂(PS)是一种脂质-蛋白质复合物,对于稳定哺乳动物肺泡的精细结构以及连续的压缩-扩张呼吸循环至关重要。为此,表面活性剂大大降低了气液界面的表面张力,这种活性严重依赖于适当的脂质组成和某些特定的表面活性剂蛋白的存在。该系统的缺乏或功能障碍与严重的呼吸道疾病有关,在某些情况下,通过补充外源性表面活性剂物质来治疗。PS 的生物物理功能和性能在健康和疾病中,直接受到其组成、结构和机械性能的影响。本综述总结了定义健康肺和病理情况下表面活性剂功能的机制背后的主要生物物理概念。它还回顾了一些最有用的生物物理技术,这些技术提供了有关表面活性剂相关过程的信息。最后,将调用转化生物物理学来说明生物物理研究如何有助于理解表面活性剂在健康和疾病中的作用,并设计更好的基于表面活性剂的治疗方法。

相似文献

1
Understanding the principle biophysics concepts of pulmonary surfactant in health and disease.理解肺表面活性剂在健康和疾病中的基本生物物理概念。
Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F443-F451. doi: 10.1136/archdischild-2018-315413. Epub 2018 Dec 14.
2
Protein-lipid interactions and surface activity in the pulmonary surfactant system.肺表面活性物质系统中的蛋白质-脂质相互作用及表面活性
Chem Phys Lipids. 2006 Jun;141(1-2):105-18. doi: 10.1016/j.chemphyslip.2006.02.017. Epub 2006 Mar 20.
3
Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy.肺表面活性物质膜的结构-功能关系:从生物物理学到治疗
Biochim Biophys Acta. 2014 Jun;1838(6):1568-85. doi: 10.1016/j.bbamem.2014.01.028. Epub 2014 Feb 11.
4
Lipid-protein interactions of hydrophobic proteins SP-B and SP-C in lung surfactant assembly and dynamics.肺表面活性物质组装与动力学中疏水蛋白SP - B和SP - C的脂-蛋白相互作用
Pediatr Pathol Mol Med. 2001 Nov-Dec;20(6):445-69. doi: 10.1080/pdp.20.6.445.469.
5
Molecular interactions in pulmonary surfactant films.肺表面活性物质膜中的分子相互作用。
Biol Neonate. 2002;81 Suppl 1:6-15. doi: 10.1159/000056765.
6
Pulmonary surfactant metabolism in the alveolar airspace: Biogenesis, extracellular conversions, recycling.肺泡气腔内的肺表面活性物质代谢:生物合成、细胞外转化、再循环
Ann Anat. 2017 Jan;209:78-92. doi: 10.1016/j.aanat.2016.09.008. Epub 2016 Oct 20.
7
Composition, structure and mechanical properties define performance of pulmonary surfactant membranes and films.组成、结构和机械性能决定了肺表面活性物质膜和片的性能。
Chem Phys Lipids. 2015 Jan;185:153-75. doi: 10.1016/j.chemphyslip.2014.09.002. Epub 2014 Sep 28.
8
Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions.肺表面活性物质膜和薄膜的结构:蛋白质及脂蛋白相互作用的作用
Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1676-95. doi: 10.1016/j.bbamem.2008.05.003. Epub 2008 May 11.
9
Molecular and biophysical mechanisms behind the enhancement of lung surfactant function during controlled therapeutic hypothermia.控制性低温治疗期间肺表面活性剂功能增强的分子和生物物理机制。
Sci Rep. 2021 Jan 12;11(1):728. doi: 10.1038/s41598-020-79025-3.
10
A ToF-SIMS study of the lateral organization of lipids and proteins in pulmonary surfactant systems.飞行时间二次离子质谱法对肺表面活性剂系统中脂质和蛋白质横向组织的研究。
Biochim Biophys Acta. 2011 Mar;1808(3):614-21. doi: 10.1016/j.bbamem.2010.11.015. Epub 2010 Nov 24.

引用本文的文献

1
Modulation of Pulmonary Fibrosis by Pulmonary Surfactant-Associated Phosphatidylethanolamine In Vitro and In Vivo.肺表面活性物质相关磷脂酰乙醇胺在体外和体内对肺纤维化的调节作用
Int J Mol Sci. 2025 Jul 24;26(15):7132. doi: 10.3390/ijms26157132.
2
Inhalable nanoparticle-based delivery systems for the treatment of pulmonary infections: and barrier-overcoming strategies.用于治疗肺部感染的基于可吸入纳米颗粒的递送系统及克服屏障的策略。
Drug Deliv. 2025 Dec;32(1):2544683. doi: 10.1080/10717544.2025.2544683. Epub 2025 Aug 11.
3
An Experimental Model of Acute Pulmonary Damage Induced by the Phospholipase A-Rich Venom of the Snake .
蛇富含磷脂酶A的毒液诱导急性肺损伤的实验模型
Toxins (Basel). 2025 Jun 12;17(6):302. doi: 10.3390/toxins17060302.
4
Surfactant protein SP-B: one ring to rule the molecular and biophysical mechanisms of the pulmonary surfactant system.表面活性蛋白SP-B:掌控肺表面活性物质系统分子与生物物理机制的关键一环。
Biophys Rev. 2025 Mar 18;17(2):653-666. doi: 10.1007/s12551-025-01285-y. eCollection 2025 Apr.
5
Predicting Surfactant Need at Birth: Failed Validation of a Bedside Method Using Gastric Aspirates.预测出生时表面活性剂需求:使用胃吸出物的床边方法验证失败
Acta Paediatr. 2025 Oct;114(10):2535-2542. doi: 10.1111/apa.70128. Epub 2025 May 10.
6
Bacterial expression, purification and folding of exceptionally hydrophobic and essential protein: Surfactant Protein-B (SP-B).异常疏水且必需的蛋白质——表面活性蛋白B(SP-B)的细菌表达、纯化及折叠
PLoS One. 2025 Apr 25;20(4):e0321446. doi: 10.1371/journal.pone.0321446. eCollection 2025.
7
Effect of therapeutic hypothermia on surfactant proteins, anti-inflammatory and pro-fibrotic mediators.治疗性低温对表面活性蛋白、抗炎和促纤维化介质的影响。
J Perinatol. 2025 Apr 2. doi: 10.1038/s41372-025-02285-2.
8
and studies of the interaction between glucocorticoid drug mometasone furoate and model lung surfactant monolayer.以及糠酸莫米松糖皮质激素药物与模型肺表面活性剂单层之间相互作用的研究。
RSC Adv. 2025 Feb 26;15(8):5951-5964. doi: 10.1039/d5ra00004a. eCollection 2025 Feb 19.
9
Review of Precision Medicine and Diagnosis of Neonatal Illness.精准医学与新生儿疾病诊断综述
Diagnostics (Basel). 2025 Feb 16;15(4):478. doi: 10.3390/diagnostics15040478.
10
New experiments and models to describe soluble surfactant adsorption above and below the critical micelle concentration.用于描述临界胶束浓度上下的可溶性表面活性剂吸附的新实验和模型。
J Colloid Interface Sci. 2025 Jan;677(Pt A):557-568. doi: 10.1016/j.jcis.2024.07.204. Epub 2024 Jul 27.